Overall and progression-free survival in endometrial carcinoma: a single-center retrospective study of patients treated between 2000-2018

被引:0
|
作者
Anfinan, Nisreen [1 ]
Sait, Khalid Hussain [1 ]
Sait, Hesham Khalid [1 ]
Alshamrani, Hanan [1 ]
机构
[1] King Abdulaziz Univ, Jeddah, Saudi Arabia
关键词
D O I
10.1136/ijgc-2024-ESGO.294
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
76
引用
收藏
页码:A154 / A155
页数:2
相关论文
共 50 条
  • [31] Assessment of Progression-free Survival as a Surrogate Endpoint for Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Negrier, S.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Sandin, R.
    Michaelson, M. D.
    Figlin, R. A.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S163 - S163
  • [32] Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
    Li, Jiayi
    Cao, Dongyan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT
    Ho, Christine M.
    McCarthy, Philip L.
    Wallace, Paul K.
    Zhang, Yali
    Fora, Ahmad
    Mellors, Patrick
    Tario, Joseph D.
    McCarthy, Benjamin L. S.
    Chen, George L.
    Holstein, Sarah A.
    Balderman, Sophia R.
    Cao, Xuefang
    Paiva, Bruno
    Hahn, Theresa
    BLOOD ADVANCES, 2017, 1 (15) : 1056 - 1066
  • [34] External validation of OroGrams as a predictive model for overall and progression-free survival in Scottish patients with oropharyngeal squamous cell carcinoma: a retrospective cohort study
    Mentel, A.
    Douglas, C. M.
    Montgomery, J.
    McMahon, J.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2021, 59 (03): : 368 - 374
  • [35] Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Nagashima, Tamon
    Namikawa, Masashi
    Tojima, Hiroki
    Shimada, Yasushi
    Takizawa, Daichi
    Naganuma, Atsushi
    Arai, Hirotaka
    Sato, Ken
    Harimoto, Norifumi
    Shirabe, Ken
    Uraoka, Toshio
    HEPATOLOGY RESEARCH, 2020, 50 (03) : 382 - 395
  • [36] Predictors of Response, Progression-Free Survival, and Overall Survival in Patients With Lung Cancer Treated With Immune Checkpoint Inhibitors
    Memmott, Regan M.
    Wolfe, Adam R.
    Carbone, David P.
    Williams, Terence M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (07) : 1086 - 1098
  • [37] TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study
    Zhang, Qiwei
    Wang, Yunbing
    Zhang, Junyong
    Zhang, Wenfeng
    Gong, Jianping
    Ma, Rong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [38] CORRELATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH OVARIAN CANCER AFTER DEBULKING SURGERY
    Chase, D.
    Mahajan, A.
    Scott, D. A.
    Hawkins, N.
    Woodward, T.
    Kalilani, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A286 - A286
  • [39] Survival outcomes and impact of minimally invasive surgery in endometrial clear cell carcinoma: single-center retrospective study
    Kim, Yong-Man
    Kim, Ju-Hyun
    Lee, Hyojeong
    Lee, Shin-Wha
    Kim, Dae-Yeon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A212 - A212
  • [40] Correlations between overall response rate, progression-free survival and overall survival in refractory small cell lung cancer treated with lurbinectedin
    Wasifuddin, Mustafa
    Ilerhunmwuwa, Nosakhare Paul
    Hakobyan, Narek
    Tahir, Muhammad
    Abowali, Hesham
    Avezbakiyev, Boris
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)